Group 1 - The core stock price of Maide Medical (688310) as of December 22, 2025, is 15.12 yuan, with a decrease of 0.26% and a turnover rate of 2.31% [1] - The net inflow of main funds on December 22 is 791.12 million yuan, accounting for 13.59% of the total transaction amount, while retail investors have a net outflow of 772.72 million yuan, accounting for 13.28% [1][2] Group 2 - Over the past five days, the stock has shown fluctuations, with a peak closing price of 15.16 yuan on December 19, 2025, reflecting a 2.57% increase [2] - The company reported a total revenue of 2.25 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 2.31%, while the net profit attributable to shareholders is 883.67 million yuan, up 15.82% year-on-year [3] - The third quarter of 2025 saw a significant increase in single-quarter revenue of 836.43 million yuan, up 54.38% year-on-year, and a net profit of 279.16 million yuan, up 224.07% year-on-year [3] Group 3 - Maide Medical's total market value is 2.513 billion yuan, with a net asset value of 840 million yuan, and a net profit of 8.8367 million yuan [3] - The company has a price-to-earnings ratio (P/E) of 213.31, which is significantly higher than the industry average of 132.02, indicating a relatively high valuation [3] - The gross profit margin stands at 40.19%, which is above the industry average of 27.79%, while the net profit margin is -2.43%, significantly lower than the industry average of 4.37% [3]